Monoamine Oxidase Inhibitors in Toxic Models of Parkinsonism
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26031248 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Olga Buneeva und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Chemistry, 10 Pogodinskaya Street, 119121 Moscow, Russia. Hauptthemen laut MEDLINE: Monoamine Oxidase Inhibitors, Parkinsonian Disorders. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Program for Basic Research in the Russian Federation for a long-term period (2021-2030).
Abstract (Originalsprache)
Monoamine oxidase inhibitors are widely used for the symptomatic treatment of Parkinson’s disease (PD). They demonstrate antiparkinsonian activity in different toxin-based models induced by 6-hydroxydopamine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and pesticides (rotenone and paraquat). In some models, such as MPTP-induced PD, MAO inhibitors prevent the formation of the neurotoxin MPP+ from the protoxin MPTP. Regardless of the toxin’s nature, potent MAO inhibitors prevent dopamine loss reduction, the formation of hydrogen peroxide, hydrogen peroxide signaling, and the accumulation of hydrogen peroxide-derived reactive oxygen species responsible for the development of oxidative stress. It becomes increasingly clear that some metabolites of MAO inhibitors (e.g., the rasagiline metabolite 1-R-aminoindan) possess their own bio-pharmacological activities unrelated to the parent compound. In addition, various MAO inhibitors exhibit multitarget action, in which MAO-independent effects prevail. This opens new prospects in the development of novel therapeutics based on simultaneous actions on several prospective targets for the therapy of PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Chemistry, 10 Pogodinskaya Street, 119121 Moscow, Russia.
Förderung
- Program for Basic Research in the Russian Federation for a long-term period (2021-2030)
Zitieren
APA
Buneeva, O., & Medvedev, A. (2025). Monoamine Oxidase Inhibitors in Toxic Models of Parkinsonism. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031248
Vancouver
Buneeva O, Medvedev A. Monoamine Oxidase Inhibitors in Toxic Models of Parkinsonism. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031248
BibTeX
@article{Buneeva2025,
author = {Buneeva, Olga and Medvedev, Alexei},
title = {Monoamine Oxidase Inhibitors in Toxic Models of Parkinsonism},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26031248}
}
EUVIMED